Nevro Corp. NVRO recently received CE Mark Certification in Europe for its HFX iQ spinal cord stimulation (SCS) system. The ...

Nevro (NVRO) announced that it has received CE Mark Certification in Europe for its HFX iQ spinal cord stimulation system. The CE marking ...

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...

Nevro (NVRO) announced that it has received CE Mark Certification in Europe for its HFX iQ spinal cord stimulation system. The CE marking allows Nevro to market HFX iQ in all countries that ...

Nov. 12, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, ...

In addition to receiving CE marking, HFX iQ received U.S. Food and Drug Administration (FDA) approval in 2022. Nevro will offer the HFX iQ system in select European countries starting in the first ...

A key highlight of the quarter came right at the end when Nevro won FDA approval for HFX AdaptiveAI, an AI-powered, ...

The CE marking allows Nevro to market HFX iQ in all countries that recognize this certification. HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines ...

"We are thrilled to receive the CE Mark Certification for HFX iQ as it marks an important milestone in our strategic path to drive market penetration through our data-backed, AI-powered SCS ...